Japan approves Eisai Co, Biogen Inc’s Leqembi for Alzheimer’s
HQ Team September 25, 2023: Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimer’s disease and cognitive impairment has been.
Drugs
Health
Pharma